{"id":"https://openalex.org/W2184886062","doi":null,"title":"COST ANALYSIS OF FINANCING DECISIONS: A STUDY OF PHARMACEUTICAL INDUSTRY IN INDIA","display_name":"COST ANALYSIS OF FINANCING DECISIONS: A STUDY OF PHARMACEUTICAL INDUSTRY IN INDIA","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2184886062","mag":"2184886062"},"language":"en","primary_location":{"id":"mag:2184886062","doi":null,"is_oa":false,"landing_page_url":"http://www.indianresearchjournals.com/pdf/APJMMR/2012/September/5.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103880044","display_name":"Sudesh Kumar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sudesh Kumar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112026957","display_name":"Bimal Anjum","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bimal Anjum","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068377820","display_name":"Suman Nayyar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suman Nayyar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5030118433","display_name":"Swami Satyanand","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Swami Satyanand","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12123","display_name":"Financial Analysis and Corporate Governance","score":0.6172000169754028,"subfield":{"id":"https://openalex.org/subfields/1402","display_name":"Accounting"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12123","display_name":"Financial Analysis and Corporate Governance","score":0.6172000169754028,"subfield":{"id":"https://openalex.org/subfields/1402","display_name":"Accounting"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10019","display_name":"Corporate Finance and Governance","score":0.336899995803833,"subfield":{"id":"https://openalex.org/subfields/2003","display_name":"Finance"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12675","display_name":"Financial Reporting and Valuation Research","score":0.035999998450279236,"subfield":{"id":"https://openalex.org/subfields/1408","display_name":"Strategy and Management"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/capital-structure","display_name":"capital structure","score":0.8389999866485596},{"id":"https://openalex.org/keywords/cost-of-capital","display_name":"cost of capital","score":1.0},{"id":"https://openalex.org/keywords/financing-decisions","display_name":"financing decisions","score":0.7689999938011169},{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"pharmaceutical industry","score":0.8679999709129333},{"id":"https://openalex.org/keywords/pharmaceutical-companies","display_name":"pharmaceutical companies","score":0.7250000238418579},{"id":"https://openalex.org/keywords/funding-sources","display_name":"funding sources","score":0.6430000066757202},{"id":"https://openalex.org/keywords/firm-value","display_name":"firm value","score":0.5659999847412109},{"id":"https://openalex.org/keywords/financial-leverage","display_name":"leverage","score":0.4000000059604645},{"id":"https://openalex.org/keywords/indian-pharmaceutical-sector","display_name":"Indian pharmaceutical sector","score":0.4189999997615814}],"concepts":[{"id":"https://openalex.org/C74734477","wikidata":"https://www.wikidata.org/wiki/Q1479274","display_name":"Cost of capital","level":3,"score":0.611133337020874},{"id":"https://openalex.org/C149933338","wikidata":"https://www.wikidata.org/wiki/Q950816","display_name":"Capital structure","level":3,"score":0.588776707649231},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.5663265585899353},{"id":"https://openalex.org/C25188504","wikidata":"https://www.wikidata.org/wiki/Q178749","display_name":"Weighted average cost of capital","level":5,"score":0.5391213893890381},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.5389142632484436},{"id":"https://openalex.org/C183582576","wikidata":"https://www.wikidata.org/wiki/Q184783","display_name":"Market liquidity","level":2,"score":0.47721773386001587},{"id":"https://openalex.org/C44750222","wikidata":"https://www.wikidata.org/wiki/Q1897397","display_name":"Financial capital","level":3,"score":0.43916261196136475},{"id":"https://openalex.org/C116168712","wikidata":"https://www.wikidata.org/wiki/Q181201","display_name":"Dividend","level":2,"score":0.4318188726902008},{"id":"https://openalex.org/C83646750","wikidata":"https://www.wikidata.org/wiki/Q193893","display_name":"Capital (architecture)","level":2,"score":0.43181583285331726},{"id":"https://openalex.org/C198082294","wikidata":"https://www.wikidata.org/wiki/Q3399648","display_name":"Position (finance)","level":2,"score":0.4281885623931885},{"id":"https://openalex.org/C181622380","wikidata":"https://www.wikidata.org/wiki/Q26911","display_name":"Profit (economics)","level":2,"score":0.42088571190834045},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.3635888695716858},{"id":"https://openalex.org/C162118730","wikidata":"https://www.wikidata.org/wiki/Q1128453","display_name":"Actuarial science","level":1,"score":0.34652531147003174},{"id":"https://openalex.org/C58202505","wikidata":"https://www.wikidata.org/wiki/Q5035700","display_name":"Capital formation","level":4,"score":0.18035820126533508},{"id":"https://openalex.org/C175444787","wikidata":"https://www.wikidata.org/wiki/Q39072","display_name":"Microeconomics","level":1,"score":0.12106922268867493},{"id":"https://openalex.org/C166957645","wikidata":"https://www.wikidata.org/wiki/Q23498","display_name":"Archaeology","level":1,"score":0.0},{"id":"https://openalex.org/C95457728","wikidata":"https://www.wikidata.org/wiki/Q309","display_name":"History","level":0,"score":0.0},{"id":"https://openalex.org/C120527767","wikidata":"https://www.wikidata.org/wiki/Q3196867","display_name":"Debt","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2184886062","doi":null,"is_oa":false,"landing_page_url":"http://www.indianresearchjournals.com/pdf/APJMMR/2012/September/5.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W2032584025","https://openalex.org/W2045528915","https://openalex.org/W2084310832","https://openalex.org/W2084943559","https://openalex.org/W2168826051","https://openalex.org/W2170790204","https://openalex.org/W2268643821","https://openalex.org/W2345378550","https://openalex.org/W2607154958"],"related_works":["https://openalex.org/W3012080066","https://openalex.org/W4406066799","https://openalex.org/W2278497959","https://openalex.org/W7171819467","https://openalex.org/W7172343492","https://openalex.org/W2205456940","https://openalex.org/W2299208878","https://openalex.org/W2972422187","https://openalex.org/W4391926440","https://openalex.org/W7217824224"],"abstract_inverted_index":{"Capital":[0],"structure":[1,43,82],"refers":[2],"to":[3,20,36,97],"the":[4,15,17,22,28,41,45,49,56,72,76,89,99,107,119,126,131,134,137],"proportion":[5],"in":[6,103],"which":[7],"various":[8,112],"long-term":[9],"financial":[10,142],"sources":[11,24,51],"are":[12,27],"employed.":[13],"Over":[14],"years,":[16],"decisions":[18,31],"related":[19],"select":[21],"appropriate":[23,50],"of":[25,47,52,58,75,91,101,109,111,121,123,140,144],"fund":[26,53],"most":[29,146],"important":[30,86],"that":[32],"a":[33,80,84,92],"firm":[34],"has":[35],"take.":[37],"This":[38,94],"is":[39,83],"because":[40],"capital":[42,81,104,110,124],"or":[44],"choice":[46],"selecting":[48],"can":[54],"affects":[55],"cost":[57,108,122],"capital,":[59],"net":[60],"profit,":[61],"earning":[62],"per":[63],"share,":[64],"and":[65],"dividend":[66],"payout":[67],"ratio":[68],"as":[69,71],"well":[70],"liquidity":[73],"position":[74],"firm.":[77,93],"So,":[78],"therefore":[79],"very":[85],"determinant":[87],"for":[88,125],"value":[90],"paper":[95,135],"attempts":[96],"measure":[98],"effect":[100],"change":[102],"structures":[105],"on":[106],"pharmaceutical":[113,148],"companies.":[114],"Similarly,":[115],"this":[116],"study":[117],"analyse":[118,130],"significance":[120],"period":[127],"2007-2011.":[128],"To":[129],"set":[132],"objectives,":[133],"include":[136],"trend":[138],"analysis":[139],"detail":[141],"information":[143],"three":[145],"reputed":[147],"companies":[149],"i;e":[150],"CIPLA":[151],"Ltd,":[152,155],"Auribindo":[153],"Pharma":[154],"Cardila":[156],"Health":[157],"Care":[158],"Ltd.":[159]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}